Solid tumors are heterogeneous with an immunosuppressive tumor microenvironment, but that is not slowing the search to treat the most difficult, recalcitrant cases ...
Heart attacks have been the leading cause of death in the United States for more than 100 years. Most current treatments ...
Researchers at Johns Hopkins University and the University of Maryland School of Pharmacy have developed a set of novel, ...
Combination therapy led to complete remission in more than 50% of mice with different tumor types, many of which were resistant to ICB therapy alone.
Federal health regulators have formally warned ImmunityBio Inc. for making misleading promotional claims about Anktiva, the ...